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The work described in this report was performed by the Project
Engineering Division of the Jet Propulsion Laboratory.
Preceding page blank
JPL Technical Memorandum 33-670
FOREWORD
In recent years the Jet Propulsion Laboratory has been encouraged by its
sponsoring agency, the National Aeronautics and Space Administration, to apply
a portion of its knowledge and abilities to important civil problems. In such
efforts, JPL works closely with members of relevant professions, representa-
tives of the public agencies, and, under special circumstances, industrial
organizations affected by the problems. When a feasible solution has been
demonstrated, the transfer of technology from the research and development
setting to the commercial marketplace is encouraged.
The development effort described herein exemplifies this approach. In
the medical field, it has been known for some time that certain devices used in
patient care are not sterilizable in all cases and that their use consequently
entails a hazard of infection. One such piece of equipment is the intermittent
positive pressure breathing (IPPB) ventilator. In the effort described in the
present document, JPL, utilizing specialized materials and techniques developed
for spacecraft sterilization, modified the design and materials of construction
of a widely used model of the IPPB so as to render it 100% heat sterilizable.
The manufacturer, the Bird Corporation, cooperated with JPL throughout the
effort, providing essential information, equipment, and services. The Bird
Corporation has now adopted dry heat sterilization as a major design criterion
for all its products wherever feasible. JPL, pursuant to its obligation to make
information concerning this technology generally available to manufacturers of
medical equipment, has prepared this document.
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SUMMARY AND CONCLUSIONS
Hospital-associated infections rank as a major cause of illness in the
United States. Over 3. 5 million patients, it is reported, are afflicted annually.
The overall economic cost approaches 10. 5 billion dollars per year.
JPL has conducted an investigation under NASA Applications Technology
Office sponsorship into hospital-acquired infections and the possibility of redu-
cing the number of such infections and the consequent cost by the application of
NASA-developed materials, design, sterilization, and environmental control
techniques. The study revealed that a major contribution to the dissemination
of infectious organisms was being made by inhalation therapy equipment which
could not be reliably sterilized. This type of equipment, because of its design
and materials of construction, could not be sterilized by heat but instead had to
be decontaminated by less efficient methods which utilized chemical or gaseous
disinfectant or decontaminating agents.
As a result of the initial phase of this study, it was decided by JPL and
NASA to attempt to develop a completely heat-sterilizable intermittent positive
pressure breathing (IPPB) ventilator in an effort to reduce the number of hos-
pital-acquired infections.
The task of developing and producing a heat-sterilizable IPPB machine
employed a coordinated team effort approach. To maintain maximal technical
support in all desired areas, a working triad was formed to define the medical,
manufacturing, material, and design problems involved in producing such a
ventilator. The teams consisted of medical doctors who specialize in inhalation
therapy; design and engineering personnel from a manufacturer of inhalation
therapy equipment; and JPL sterilization, materials, and design personnel.
After appropriate changes in materials and design were made, six proto-
type units were fabricated and were successfully field tested in local hospitals.
Most components of the modified ventilators are compatible with existing
machines. In all but a few instances, such as installation of bacteria-retentive
filters and a modified venturi, the changeover from non-heat-sterilizable to
sterilizable units was accomplished by replacement of heat-labile materials with
heat-stable materials.
JPL Technical Memorandum 33-670 viiPreceding page blank
The results of this project have shown that, by the use of alternative
materials and concomitant modification of design, it is possible to convert an
important non-heat-sterilizable medical device to one that is completely heat
sterilizable, thus permitting elimination of a potential source of hospital infec-
tions. Information gained from this study indicates that application of the same
technologies successfully used to produce a heat-sterilizable IPPB unit could
permit the development and fabrication of other heat-sterilizable medical equip-
ment to replace heat-labile apparatus now in use.
As a direct consequence of this task and the practical application of rele-
vant NASA-developed spacecraft sterilization technologies to the medical device
field, the Bird Corporation, manufacturer of the patient ventilators chosen for
study and redesign, has been thoroughly convinced* that the dry heat method
of sterilization is far superior to any other method or methods currently avail-
able and in use for their equipment. Consequently, the Bird Corporation intends
to incorporate dry heat sterilization capability as a major design criterion in all
of its products wherever possible. Because of the enthusiasm generated by
JPL for the heat sterilization concept, the Bird Corporation has initiated a
parallel project. This consisted of converting a smaller, less complex (Mark I)
ventilator design to heat sterilizable materials. It is planned to produce several
hundred of these smaller units and to introduce them to the medical field on a
large scale for evaluation. Bird has expressed confidence in dry heat sterili-
zation as the most efficient and effective method for sterilization of not only
inhalation devices but most other hospital equipment as well.
*See letter, Appendix A.
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ABSTRACT
More than 3. 5 million patients in the United States are
reported to be afflicted with hospital-associated infections each
year, resulting in an overall cost approaching 10. 5 billion dollars
per year. A considerable amount of medical apparatus, because
of its incompatibility with reliable sterilization methods, is impli-
cated in the transmission of disease-producing microorganisms.
One such device, an intermittent positive pressure breathing
(IPPB) apparatus, was modified in conjunction with a manufac-
turer to demonstrate the feasibility of converting an existing
apparatus to one which is compatible with dry heat sterilization.
This sterilization method has been proven to be capable of highly
efficient, consistent, reliable, total destruction of all bacterial
and viral forms of life.
NASA-developed material, design, and sterilization
technologies were utilized to effect the appropriate modifications
to this apparatus. Prototype units produced are capable of with-
standing repeated sterilization cycles at 1250C. The results of
hospital field testing substantiated the effectiveness of this effort.
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SECTION I
STATEMENT OF THE PROBLEM
It has been reported that more than 3.5 million patients in the United
States are afflicted with hospital-associated infections each year, resulting in
an overall cost approaching 10.5 billion dollars per year (Ref. 1).
Constant awareness of the modes of dissemination and transmission of
disease-producing organisms in health care facilities, and a continuing search
for methods to prevent their spread, are prerequisite to reducing this infection
rate and planning a defense against the spread of infectious agents from one
person to another within these facilities.
Prior to the work reported here, studies had been conducted to investigate
the newest concepts of medical-facility-induced infections and the relationship
between infection rate and microbial contamination in the environment (Ref. 2).
These studies revealed the existence of a major factor in the dissemination and
transmission of infectious organisms. This factor is non-heat-sterilizable
medical equipment, and is of great concern to medical personnel. In many types
of induced infections, it has been implicated as the primary transmitter of infec-
tious organisms. Such equipment, which is rendered non-heat-sterilizable by
virtue of materials of construction or design of the equipment, must be decon-
taminated by chemical agents. Chemical agents cannot always be relied upon
to sterilize because of such things as physical complexity of the equipment
(which may prevent decontamination of all parts), the types and numbers of
microorganisms present, or other conditions which may exist at the time of
sterilization is attempted. Medical apparatus which have been implicated in the
spread of infectious organisms include respiratory, inhalation therapy, and
anesthesia equipment (including the ancillary humidifying apparatus); incubators;
nebulization equipment; and mist therapy units. Cystoscopes, suction equipment,
and air compressors have also been implicated but not to such a high degree.
A definitive examination of the medical literature pertaining to non-heat-
sterilizable, infection-implicated instruments revealed that the most culpable
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class of instruments was inhalation therapy and anesthesia equipment and within
this class, more specifically, Intermittent Positive Pressure Breathing (IPPB)
apparatus (Refs. 3-7). It was also determined that a large proportion of the
medical professionals knowledgeable in inhalation therapy consider nonsterile
IPPB apparatus to be a major contributor to, and source of, infection. Many of
these experts believe that this apparatus is involved primarily because it is
incompatible with reliable sterilization processes and this incompability prevents
complete removal or inactivation of infectious microorganisms associated with
the equipment (Tables 1 and 2). Evidence derived from microbiological studies
also indicates that the remaining viable organisms can multiply rapidly in a high
humidity environment such as that present in the machine (Ref. 8).
Intermittent positive pressure breathing devices are used to treat asthma,
emphysema, obstructive pulmonary disease, and some cases of respiratory
failure. They can breathe for a patient or be used to introduce oxygen, air, or
medication into the lungs. They are required in many cases to ventilate critically
ill patients with an indwelling endotracheal tube or tracheostomy, or postoperative
patients with respiratory problems.
These devices can be adjusted to assist or control the rate and depth of
pulmonary ventilation. Both the inspiratory and expiratory phases of spontaneous
respiration can be mechanically assisted by this device to increase the gas volume
during inspiration and enhance the outward flow of gases from the lungs during
expiration. When a spontaneous respiratory pattern ceases to exist the patient
may have both the rate and depth of pulmonary ventilation controlled mechanically
by the unit. The difference between normal respiration and that produced by the
machine can be seen in Fig. 1.
The ventilator is actuated by differential gas pressure and needs no other
power source; therefore, it is safe to use in the presence of anesthetic gases.
The pattern of gas flow which actuates the machine can be seen in Figs. 2 and 3.
A detailed functional diagram appears in Fig. 4.
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H Table 1. Methods used by cooperating hospitals to clean and decontaminate IPPB apparatus
Hospital Number of Types of Types of Disinfectant Used Was Ethylene Oxide Used to
S Hospital Number pts Procedures Equipment Equipment Basic Cleaning Procedure fdnSterilize After How qipmen Was
Number Per Month Used Sampled Decontamination?
1 30 7000 Bird Bennett Disassemble equipment Cidex No No packaging
Bennett and soak in Cidex 10-15
min. Wash in detergent,
rinse and drip dry.
2 9 1600 Bennett Bennett Soak and wash in Micro- Micro-Quat Yes No packaging
Quat. Soak in Cidex and Cidex
rinse in cold running water.
L3 2 Therapists 1600 Bird Bird Soak in detergent and Cidex (Data missing) Yes Plastic bags
8 Technicians Bennett and wash manually. Put
O equipment in dishwasher,
add Cascade detergent, and
O Iwash full cycle at 60 ° C.
Air dry with compressed
air. Place in bags.
4 3 475 Bird Bird 3 Tub Cleaning Procedure: Chlorine No Plastic bags
Bennett Ist Tub - Soak 10 min in Zepheran
15% CI z , rinse in HZO for15 min; 2nd Tub - Soak for
2 mrin in15% C1 2 and rinse;
3rd Tub - Rinse in 1:1000
Zepheran and air dry.
5 z12 425 Bird Bird Wash in hot Dreft solution, Dreft Yes Plastic heat-
Bennett rinse in tap water, force sealed bags and
air dry and steam or gas Tupperware boxes
sterilize.
6 (Data missing) (Data Bird Bird Manual prewash; (Data missing) Yes Polyethelene bags
missing) Bennett mechanical wash and
rinse.
These data on IPPB apparatus were the result of studies conducted by the
American Public Health Association in conjunction with the United States
Public Health Service.
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Table 1. (Contd)
Hospital Number of Number of Types of Types of Disinfectant Used Was' Ethylene Oxide Used to How Equipment Was
Code oProcedures Equipment Equipment Basic Cleaning Procedure to Decontaminate Sterilize Afterfor Storage
Number Per Month Used Sampled Decontamination?
7 14 1400 Bennett II Bennett Soak 24 hours in Cidex, Instra-San No Plastic bags
Bird 10 min. in Instra-San, Cidex
Emerson scrub, rinse in H 0,
soak in Cidex 10-20 min.,
soak in Instra-San 10 min.,
rinse in HZO, and dry by
hot air.
8 12 1800 Bennett Bennett Wash in ultrasonic cleaner Cidex Yes Plastic bags and
Bird for 7 min, soak in Cidex Morcept plastic boxes
Air Shields 60 min., rinse, and
Ohio air dry.
9 (Data missing) 240 Bennett Bennett Soak 30 min. in Micro- Micro-Quat Yes Plastic wrapped
Quat, brush, rinse in
hot H 2 0, and air dry.
Cr
o
Il
0
-- 1
-3 Table 2. Types of organisms isolated from IPPB units after cleaning and decontaminating
0
Types of Part Assayed and Results
Main Line Tubing Nebulizers Manifold
O % of Number of % of Number of % of Number of
Hosp. Number Parts Org. Per Number Parts Org. Per Number Parts Org. Per Types ofOrganisms Isolated
No. Tested Positive Sample* Tested Positive Sample* Tested Positive Sample*
1 23 52 0-200 23 48 0-100 23 26 0-125 Staphylococcus epidermidis, Bacillus
Actinomyces, Microccus, and
Alcaligenes species
2 20 50 0-7350 14 50 0-50,000 20 80 0-25 Klebsiella-Enterobacter group, E.
Wcoli, Staph. aureus, Bacillus,
Gaffkya, and Pseudomonas species
and diphtheroids
-J
o 3 25 16 0-1000 25 32 0-2600 25 40 0-500 Staph. epidermidis, Klebsiella-
Aerobacter group, Bacillus,
Corynebacterium, Streptococcus,
and Pseudomonas species
4 (Data not reported as requested)
5 (Data not reported as requested)
6 21 (Data 0-10 (Data (Data 0-500 (Data (Data 0 Staph. albus, Klebsiellagroup,
missing) missing) missing) missing) missing) Bacillus, and Enterobacter species
7 19 53 0-14, 080 20 50 0-60, 000 20 55 0-14,400 Staph. epidermidis, Alcaligenes
fecalis, Enterobacter cloacae, and
Bacillus species
8 27 4 1400 27 40 0-100 27 22 0-40 Strep. viridans, Gaffkya tetragna,
Bacillus megaterium, Coryne-
bacterium Hoffmannii, Staph. albus,Pseudomonas, and Flavobacterium
species
9 10 10 0-680 (Data (Data Staphylococcus species
missing) missing)
_ I I I I
This is not to be construed as total present per part tested.
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During use of IPPB the pressure within the chest's airways is positive during both
inhalation and exhalation.
During normal respiration a negative pressure within the airways of the chest is
normal during inhalation, becoming positive during exhalation.
Fig. 1. Normal respiration vs. IPPB pressure cycles
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Fig. 4. Detailed diagram of modified unit showing
ambient filter, pressurized filter, and
modified (sealed) venturi
SECTION II
TASK OBJECTIVE AND APPROACH
A. OBJECTIVE
The objective of this task was to design and produce a completely heat-
sterilizable IPPB apparatus made up of NASA-proven dry-heat-sterilizable
materials.
B. OVERALL TASK APPROACH
To meet this objective, it was deemed necessary to examine existing
ventilators in order to identify those parts which were not compatible with either
steam under pressure or dry heat; to determine the reasons for incompatibility;
to propose changes in materials and design as required; to complete a prelimi-
nary design incorporating the proposed changes; and, finally, to build and field
test a prototype unit incorporating all the suggested changes. An additional
step was to define and prove out a heat-sterilization time and temperature that
would not damage the apparatus and would produce rapid, consistent steriliza-
tion.
For the task of developing and producing a heat-sterilizable IPPB machine,
a coordinated team effort approach was employed. To maintain maximal tech-
nical support in all desired areas, a working triad was formed to define the
medical, manufacturing, material, and design problems involved in producing
such a ventilator. The teams consisted of medical doctors who specialize in
inhalation therapy; design and engineering personnel from a manufacturer of
inhalation therapy equipment; and JPL sterilization, materials, and design
personnel. JPL has had extensive experience in developing sterilization methods
and requirements, as well as in determining materials compatibility (Refs. 9,
10). This, combined with a knowledge of the design requirements of complex
sterilizable space hardware, provided the background of information and exper-
ience required to make a definitive study of such a complex equipment as an IPPB
apparatus and to determine the feasibility of making it heat sterilizable.
JPL Technical Memorandum 33-620 11
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A review of the design of the apparatus by JPL materials and design per-
sonnel indicated that the device could probably be made dry heat sterilizable by
certain design changes and the use of existing materials, proven by JPL's
Materials Section to be capable of withstanding sterilization temperatures for
long periods without degradation or production of toxic by-products.
The manufacturer of the equipment used in this study furnished all the
machines, parts, and technical assistance required, on a no-cost to JPL basis,
and agreed to build prototype units based on JPL's suggested modifications. He
also made a positive commitment to explore the commercial feasibility of using
the concepts and approaches developed by the team and to permit the develop-
ment reports to appear in the open literature so that other manufacturers of this
type of equipment could benefit from the study. In addition, the manufacturer
provided a complete set of drawings of his equipment, and gave the reasons for
his choices of materials and his design rationale.
C. OVERALL TASK DISCUSSION
1. Task Structure
This task was structured to include and give consideration to the following
actions:
1) Enlist the aid of medical personnal and gain their support.
2) Gain the support of medical equipment manufacturers.
3) Form working groups of medical, industrial, and JPL personnel.
4) Identify the major elements of work to be performed.
5) Determine and designate the responsibilities of the working teams
and team members.
2. Medical Team Personnel and Responsibilities
After it was established that the medical equipment to be worked with
would be an IPPB apparatus, it was necessary to contact inhalation therapy per-
sonnel at various hospitals to enlist their aid in defining their needs and require-
ments. Four inhalation therapy departments of hospitals in the Los Angeles
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area were visited and discussions were held with inhalation therapists, as well
as directors of the departments. A team composed of the directors of inhalation
therapy from each of the four hospitals was formed and they agreed to assume
the following responsibilities:
1) Render technical assistance to the JPL team by demonstrating how
the machines are used, disassembled, cleaned, decontaminated,
reassembled, and put back into use.
2) Indicate the most acute problem areas in terms of contamination
levels within the machine, difficulty in cleaning, and prevention
of contamination of "clean" machines by patients and personnel.
3) Point out areas of most intimate contact between patient and machine
that appear to present the greatest potential hazard for recontami-
nation of the apparatus.
4) Make equipment available to the JPL team as required for non-
destructive examination and experimentation.
5) Give professional advice and guidance as required.
6) Render judgment as to the usefulness and applicability of new
materials and designs as developed.
3. Considerations Involved in Determining Manufacturers' Acceptability
Based on discussions with the above and other medical personnel about the
type of equipment used in their facilities, a list of IPPB apparatus manufacturers
was prepared.
Before the manufacturers of this type of ventilating equipment were
approached, criteria were developed to determine which companies would be
most acceptable to JPL and the medical team. The criteria used to establish
preference were as follows:
1) Medical team's experience with company and equipment.
a) Performance of equipment under conditions of use, i. e.,
whether the device adequately and easily does what it is sup-
posed to do.
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b) Reliability of apparatus and company.
c) Impressions of company personnel (capabilities and coopera-
tiveness).
d) Personal contacts - ease of working with company personnel
and satisfaction with their response to hospital and medical
personnel demands.
2) Geographical location of manufacturing facility (proximity to JPL).
3) Ease of demonstration (device easy to work with - not complex).
4) Percent of market (number of machines in use).
5) Degree of commitment of manufacturer - willingness to cooperate
in new developments, as determined from prior activities.
On the basis of the above criteria, four companies were considered and
contacted; however, it was subsequently decided to work with only one company.
The decision to choose only one manufacturer was based on the following ration-
ale:
1) IPPB devices made by different manufacturers are not made of the
same materials and are of different designs, thus making it complex
and costly to work with more than one manufacturer's apparatus.
2) JPL manpower and travel costs would be prohibitive if several com-
panies, widely separated geographically, were involved in the study.
Two manufacturers of IPPB apparatus are located in California.
Both were contacted. One agreed to the JPL terms and conditions;
the other was not interested in cooperating in the study under the
terms and conditions stipulated by JPL.
3) The "triad concept, " in which JPL, doctors, and manufacturers'
personnel teams would work closely together, would be almost
impossible to attain because of the scheduling difficulties that would
arise when attempting to conduct meetings and seminars to be
attended by team members from several companies located in widely
scattered geographical areas.
4) A manufacturer could not be expected to expend large sums of money
and time traveling from widely separated geographical areas to
Southern California to attend the all-important meetings of the work-
14 ing group. JPL Technical Memorandum 33-670
5) If too many individuals with vested interests were involved, the
spirit of cooperation and team rapport might be severely diluted.
On the basis of the above criteria and rationale the Bird Corporation,
Palm Springs, California, was chosen.
4. Why Bird Corporation?
1) Our survey indicated that the majority of IPPB apparatus used in
health care facilities and teaching institutions in the Los Angeles
area is manufactured by this one company. Thus, it follows that
the greatest number of patients would benefit from this task if this
company's apparatus was studied and made heat sterilizable. By
working with this one organization, a completely successful program
could mean the greatest potential for reduction in infections caused
by contaminated IPPB apparatus. It was concluded that the maximum
technology transfer impact per dollar would be realized by this
working arrangement.
2) The manufacturer is located in Southern California in close proximity
to JPL and members of the medical team, thus simplifying working
arrangements.
3) A minimum of time and money would be required for travel and trans-
portation of equipment to and from JPL.
4) All members of the medical team or their staffs involved in this
study are fully acquainted with the construction and function of this
equipment and most are able to disassemble, repair, and reassemble
the equipment as required, thus aiding in the evaluation of proposed
changes in the apparatus in relation to probable effects on patient
response.
5) A firm commitment was received from Bird Corporation to work
under the following terms and conditions stipulated by JPL.
The manufacturer agreed to work with JPL on a no-cost-to-JPL basis and:
1) Furnish all the required IPPB apparatus free of charge for JPL use.
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2) Give a positive commitment to explore the commercial feasibility
of using the concepts and approaches developed by the JPL team
and to issue a product development report.
3) Furnish a complete set of working drawings.
4) Give reasons for choice of materials.
5) Give the design rationale.
6) Permit unlimited consultation with the company's designers.
7) Furnish information on cost analysis and marketing methods if and
as required.
8) Permit public information release of any new technology developed
as a result of the study.
In addition to the above, the following specific responsibilities of the man-
ufacturer's team were developed during meetings between JPL and their engin-
eering, design and fabrication personnel. They agreed:
1) To render technical assistance to the JPL team by furnishing equip-
ment needed for experimentation and engineering assistance as and
when required by JPL material and design personnel.
2) To furnish information on the physical and chemical properties of
the materials used in present as well as future or proposed designs
if not of a proprietary nature and if release of such information did
not constitute a patent infringement.
3) To render opinions as to the usefulness, applicability, and impact
on cost of proposed materials and designs.
The JPL team consisted of one materials engineer, one design engineer,
and one life science engineer (microbiologist) serving as overall task manager.
The team's responsibilities were to
1) Examine existing equipment and, with the aid of the other team,
identify those parts which were not heat sterilizable and the reasons
for sterilization incompatibility.
2) Identify the changes necessary to make those parts heat sterilizable.
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3) Determine alteration feasibility and identify materials which
are heat sterilizable and which could be substituted for existing
heat-labile materials.
4) Suggest changes in design which are necessary to produce a heat-
sterilizable machine.
5) Define new material and fabrication approaches.
6) Establish a dry heat sterilization cycle capable of achieving consis-
tent sterility of the equipment.
7) Generate a list of heat-sterilizable components which were not
previously heat sterilizable.
8) Present all recommendations, materials, and methods to the
medical profession and manufacturing teams for their use.
As a result of this team effort, it was established that the medical pro-
fession and the manufacturers of IPPB devices would be receiving the benefit
of JPL's experience in the development of heat-sterilizable materials, the
design of heat-sterilizable spacecraft, and the development of improved sterili-
zation methods. In addition, they would have access to the large amount of
information already in existence at JPL on polymeric materials in common use
in the aerospace industry that have been tested and found to be able to withstand
thousands of hours at the suggested sterilization temperature without alteration
of physical properties.
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SECTION III
MICROBIOLOGICAL PROCEDURES AND RESULTS
The temperature needed to achieve consistent sterilization of any equip-
ment, especially within a reasonable period of time, directly affects its material
and design requirements. Therefore, to determine the equipment requirements,
it was necessary to first define the approximate sterilization cycle. Initial
determinations of the times and temperatures required to sterilize IPPB appar-
atus were based on the death rates of organisms isolated from "patient used",
contaminated current-model breathing head assemblies obtained from one of
the hospitals cooperating in the study.
The death rate or D value of an organism is the time in minutes at a con-
stant temperature necessary to destroy 90% of the organisms present. On
semilog paper, the number of organisms is plotted on the logarithmic scale
against time in minutes on the linear scale, and the best straight line is drawn
through them. The D value is the time in minutes required for this curve to
traverse one logarithmic cycle. A subscript denotes the temperature to which
D relates. For example, D 1 0 0 refers to the death rate at 100*C, while D 1 2 5
refers to the death rate at 125 0C.
A. PROCEDURES USED FOR MICROBIOLOGICAL ASSAY OF INTERMITTENT
POSITIVE PRESSURE BREATHING APPARATUS
Ten current-model units, with the configuration shown in Fig. 5, were
obtained from a local hospital. The units were picked up from the ward where
they had been used, placed in sterile plastic bags, and sealed to prevent further
contamination. The units were then transported to JPL for microbiological
assay.
Once in the laboratory, the bags were opened aseptically and the units
were disassembled into their component parts. Each individual part which was
to be sampled was placed in a thin-walled beaker and immersed in a sterile
phosphate buffer solution. The buffer solution consisted of distilled water,
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Fig. 5. Intermittent positive pressure breathing apparatus
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potassium dihydrogen phosphate, and 0.02%/ v/v Tween 80. The pH was adjusted
to 7.2 ± 0.1 through the use of sodium hydroxide.
The beakers containing the parts and buffer solution were then insonated
at 25 kHz in a tank containing an aqueous solution of 0. 3% v/v Tween 80. The
sonicated fluid from the beakers was then passed through a 0.45-micron cellulose
filter after which the filters were plated on Eugon agar and incubated for 72 hours
at 37"C.
The burden for each part is shown in Table 3. The note for each unit
reflects the number and duration of sonications which each part underwent.
The units were processed in sets of five. It was noted in assaying the first five
units that most of the samples had extremely high counts in the mouthpiece,
trach-tube adapter, and premouth tubing parts. Therefore, it was decided to do
a 10-fold serial dilution on the fluid obtained from these parts in order to be
able to more accurately count the colony centers on the filters. Samples desig-
nated with three asterisks (***) have had their burden derived from these
dilutions. The double asterisk (**) indicates that an extrapolation factor was
incorporated in the total burden determination on that part. For each type of
tubing a 3-inch (76.2-mm) section was sampled and the burden was extrapolated
to the total length of tubing. One hundred milliliters of liquid was taken from
each 500 ml inline nebulizer and filtered. The burden was then extrapolated to
reflect the total volume of the nebulizer at the time it was sampled.
B. PROCEDURES FOR THE SELECTION, PURIFICATION, AND DRY
HEAT TESTING OF IPPB ISOLATES
Three isolates were recovered from each of the 10 apparatus tested and,
where possible, from different parts on the apparatus. Isolates were picked
on the basis of their gross colonial morphology and ease of recovering a pure
colony.
The isolates were recovered from the filters using a sterile loop. The
selected isolates were purified on prepoured Eugon agar plates using the
quadrant streak method and then incubated at 37°C for 48 hours.
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Table 3. Total bacterial burden on individual parts*
Small
Mouth Tracheal Pre- Exhalation Micro- Micro- Tube Small Large Nebulizer
Unit Piece Tube Mouth Valve Neb. Neb. Elbow Off Tube Tube** Fluid**
Adapter Tubing** and "T" (Clear) (Cloudy) Micro- (Gas)**
Neb. "
la TNTC NS 6000 900 7 619 400 6 NS 312 NS
2b  NS NS 1920 750 216 178 12 NS NS 51,600 24
3c  NS TNTC TNTC TNTC TNTC TNTC TNTC 5400 NS TNTC 4
4c  NS NS TNTC 34 99 960 103 228 NS 6072 NS
5c  NS TNTC TNTC 15 TNTC 26 NS NS NS 1464 8
6 c NS NS 1020 3 22 11 1400 138 NS 1896 0
7c  NS NS 77 2 144 15 1 72 NS 1800 0
8c  18, 000*** NS 1920 1 TNTC 32 TNTC NS 720 1296 14
9
c  
102, 000*** NS 3120* 0 33 52 NS 234 NS 1392 0
10c  37, 500** NS 864 14 TNTC TNTC 5 3120 NS 1680 0
Average 52,500 --- 2131 215 86 236 320 1314 720 7501 6
Notes:
aThree 2 -minute sonications at 25 kHz. *See Fig. 5 for parts identification.Sbone 2-minute sonication at 25 kHz. **Total burden determined by extrapolation.
SCOne 12-minute sonication at 25 kHz. ***Count determined by dilution plate.
NS = not sampled.
TNTC = too numerous to count.
0
0
I(A0,
After purification, a final streak was made for the purpose of taking notes
on the gross colonial morphology. The material for streaking was obtained
from a broth culture which had been incubated at 370 C for 24 hours. Then 0.2 ml
of the broth suspension was transferred to sterile Eugon agar slants, incubated
at 37°C for 48 hours, and stored at 4 0 C for later use.
When needed for dry-heat testing, the isolates were washed off the slants
with Eugon broth. Lawns were made on prepoured Eugon agar plates. The 48-
hour lawns were harvested on the day of the test. The isolates were washed off
the plates with 20 ml of cold sterile distilled water. The resulting suspension
was centrifuged for 10 minutes at 9750 relative centrifugal force. The washing-
centrifugation procedure was performed four times.
The bacterial concentration of the suspension was obtained by spectro-
photometric means, utilizing the Spectronic 20. A sample of the washed suspen-
sion was added to a cuvette containing 4 ml of distilled water to obtain an absorb-
ance value of 0. 50. This produced a titer of between 10 and 107 organisms/ml.
An Eppendorf pipet was used to deposit approximately 105 organisms on sterile
25 x 50 mm stainless steel coupons. The inoculated coupons were allowed to
air dry for approximately 30 minutes before being placed in a dry heat oven
which was set at 100'C. Pull times were zero time (non-heat-treated), 5, 8,
12, and 16 minutes, respectively. After being removed from the oven the
coupons were placed in flasks containing 20 ml of a 10/ peptone solution and
sonicated for 2 minutes. Following sonication, appropriate 10-fold serial
dilutions were made and plated out with Eugon agar. After incubating the plates
at 37 0 C for 48 hours, colony-forming units were counted.
Linear regression analysis was performed with the results shown on
Table 4. The results show that most IPPB cocci tested were rendered non-
viable within the first 10 minutes at 100*C. Some sporeforming and nonspore-
forming rods were also tested. For three of the sporeformers the D100OC
values are not shown in Table 4 because, at the time of testing, they were
mostly in the spore state as a result of the culturing techniques used; it was
thought that on the apparatus itself the conditions required for sporulation would
probably not be present. In the two cases where nonsporeforming rods were
tested, they died off in less than 5 minutes at 100 0 C, as shown in Table 4.
JPL Technical Memorandum 33-670 23
Table 4. D 000 C values of selected IPPB isolates
Apparatus/
Organism Part Code* Type Gram Stain D 1 0 0 0 C(min)
1 1-MP** Yeast + 5
2 1 -MP Rod - 5
4 2 -NF Yeast + 7
6 Z-LT Coccus 6
7 2-LT Rod - Not tested
8 3-TTA Rod - <5
9 4-E Rod - Not tested
10 6-STM Coccus + 6
11 6-STM Coccus ± 5
12 6-STM Rod + Not tested
13 8-MP(1) Coccus + 7
14 8-PMT Coccus + 11
15 8-STG Coccus + 8
16 9-MP Coccus 8
17 9-MP Coccus + 5
18 10-MP(1) Coccus + 24
19 10-PMT Coccus + 5
*Numbers in front of letters code correspond to apparatus numbers
**The letter codes are as follows: E - elbow, LT- large tube,
MP - mouthpiece, NF - nebulizer fluid, PMT - premouth tube,
STM - small tube micronebulizer, STG - small tube (gas),
TTA - tracheal tube adapter.
"(1)" indicates first dilution.
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An attempt was made to establish D values for the isolates at 110 0 C as well as
1.25°C, but the organisms died off too rapidly to permit a determination at the
higher temperature.
In any event, the primary purpose of establishing the D values of the
isolates was to initially define the approximate dry-heat cycle which would have
to be used to sterilize IPPB apparatus. It was decided that the actual steriliza-
tion cycle would have to be determined by exposing naturally occurring organisms,
found on patient-used apparatus, directly to the predicted sterilization cycle. It
was further decided that, even though the likelihood of spores being present was
rather remote, they too would be included, in the form of spore strips, and
exposed to the sterilization cycle along with patient-contaminated assemblies.
C. DETERMINATION OF THE DRY-HEAT-STERILIZATION CYCLE
FOR IPPB APPARATUS
An evaluation of the data on the types of organisms isolated from conven-
tional apparatus and their dry-heat resistance indicated that the most heat-
resistant organism had a D 1 0 0 value of less than 30 minutes. D values at higher
temperatures could not be determined due to the heat sensitivity of the organisms.
The number of organisms obtained from the individual parts assayed was then
extrapolated to a complete unit in order to determine the total number of organ-
isms present. In the"worst case" condition the number of organisms on a com-
plete unit was 1 x 107
On the basis of a D value of 30 minutes at 100°C, the number of organisms
present on each unit, and the time required for the. most slow-heating part of the
unit to reach oven temperature, it was estimated that a total cycle time of
6 hours at 1250 C should be more than adequate to sterilize the units.
Studies were then initiated utilizing the new dry-heat-sterilizable units.
Since naturally occurring microorganisms are generally more difficult to kill
than cultured organisms, it was decided to expose patient-contaminated heat-
compatible breathing head assemblies (the most contaminated part of the unit)
to the proposed sterilization cycles and then culture the entire assemblies to
check for sterility.
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Six prototype control units and 36 breathing circuits, which included all
tubing and breathing-head components, were fabricated by Bird Corporation
according to JPL's suggested materials and design modifications.
These units were initially sterilized for 8 hours at 1250 C in a forced-
circulation dry-heat oven using a drive temperature of 127C. The units were
sterilized in sealed bags and delivered to the cooperating hospitals. Each of
2 hospitals received 3 units and 18 breathing heads. Once a week the control
units and breathing-circuit components were brought back to JPL for processing
as follows:
1) The control units were examined for defects in construction or
function and adjustments made if required.
2) The control units were sealed in bags and sterilized at 1250C for
6 hours and returned to the hospitals along with sterile breathing
heads.
3) The contaminated breathing head assemblies were placed in bags
and sealed. They were then exposed to a sterilization cycle of
either 2, 4, or 6 hours at 125 0 C.
4) After exposure to the above cycles the heads were disassembled
without opening the bags, then the parts were removed from the
bags aseptically, in a laminar flow hood, and placed in half-gallon
screw-cap bottles containing Trypticase Soy Broth (TSB).
5) The parts were incubated at 37 0 C for 5 days and examined for growth.
6) After 5 days the parts and broth were autoclaved for at least 1/2
hour at 121 0 C before removal of the parts and subsequent washing.
7) After washing and drying, the parts were assembled and the
breathing head assemblies were bagged, sterilized for 6 hours, and
returned to the hospitals.
8) Some contaminated units were placed directly into the broth to be
used as positive controls to check the culture medium.
9) Some units which had not been sent to the hospitals but had been
sterilized in the same manner as contaminated units, were used as
controls to verify the techniques being used to make sure that the
manipulations were not introducing contamination.
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10) In addition to the above component controls, commercially available
spore strips were placed in the oven along with the contaminated
parts, to determine if the cycle was adequate to kill spores, which
are much more difficult to destroy than the vegetative cells that
make up the greater proportion of the bacterial population found on
the ventilators.
The above process was repeated for the duration of the testing period of
2 months with exception of the 2-hour cycle, which was deleted because it
failed to sterilize.
The results of these studies (Table 5) indicate that a 4-hour cycle at
125 0 C is adequate to sterilize the modified IPPB units; however, to increase
the probability of sterility and to take care of the "unusual" case, it is recom-
mended that the sterilization cycle be 6 hours at 125°C. In JPL's oven, fully
loaded with 6 complete units and 16 extra breathing-head assemblies, all
individually sealed in plastic bags, it took 1 hour for the coldest part of the units
to reach temperature. Thus, the total length of time in the oven was 7 hours.
D. AMBIENT AIR AND PRESSURIZED GAS FILTRATION REQUIREMENTS
To prevent contamination of the sterilization unit and the patient by
microorganisms contained in the ambient air or in the pressurized gases used
to operate the ventilator, a bacteria-retentive filter system (Fig. 3) was
installed.
The operating characteristics of the IPPB unit demanded a high efficiency,
high flow rate, low resistance filter in the ambient air stream. For the pres-
surized gas filter, the primary requirement was high efficiency filtration; flow
rate and resistance requirements were of secondary importance.
Extensive research by JPL in the microbiological evaluation of high-
efficiency filters for liquids and gases (Refs. 11, 12) and a thorough literature
search in this area, furnished information on which to base the fabrication of a
dry-heat-sterilizable filter having the needed characteristics.
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Table 5. Time required to sterilize patient-contaminated respirator
breathing-head assemblies using dry heat at 1250C
Hours Spore Strip Controls*
Test Exposure Number Number Percent Number Number Percent
No. at 125*C Exposed Sterile Sterile Exposed Sterile Sterile
0 -- 2 0 0
2 2 0 0
4 2 2 100
6 2 2 100
0 2 0 0
2 2 0 0
4 2 2 100
6 2 2 100
0 2 0 0 2 0 0
32
4 8 8 100 2 2 100
6 9 9 100 2 2 100
0 2 0 0
4 4 9 9 100 6 6 100
6 9 9 100 6 6 100
0
5 4 9 9 100
6 9 9 100
0 2 1 50
6 4 9 9 100 2 2 100
6 9 9 100 2 2 100
0 4 0 0
7 4 9 9 100 6 6 100
6 9 9 100 4 4 100
0 6 0 0 10 1 10
2 4 0 0Totals 4 48 48 100 16 16 100
6 49 49 100 14 14 100
*Spore strip controls used: Bacillus subtilis, Bacillus stearothermophilus.
**Time 0 exposed assemblies and spore strips were positive controls.
* -Two-hour exposure was deleted at this point because of previously
determined inability to sterilize.
Both the ambient and pressurized gas filters are compound filters made up
of layers of urethane foam and fiberglass filter material. The type of fiberglass
filter material used has had extensive use as an air filter medium for germ-free
animal isolators (Ref. 13) and for the removal of bacteria from oxygen used
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clinically (Ref. 14). The urethane prefilter is used to prevent premature plug-
ging of the fiberglass filter medium; the post filter is used to prevent any possible
migration of filter particles into the ventilator.
After fabrication the filters were tested under the same conditions of
differential pressure and gas flow volume as would be encountered in actual use.
The gases were permitted to flow through the filters for several hours in an
attempt to collect any particles of fiberglass which were present; 0.45-micron
black, gridded membrane filters were used. The counting was done with a
microscope at 150 power. The results obtained from counting six ambient and
six pressure filters indicated that no particles of fiberglass were present on any
of the membrane filters.
The filters were not challenged with bacterial aerosols because the data
available in the literature indicates that the fiberglass filter material used in
this application - and used in this same or similar configuration - is indeed an
absolute filter, capable of removing 100% of the bacteria which may be present
in an air or gas stream (Refs. 13, 14).
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SECTION IV
MATERIALS
A. DEFINITION OF REQUIREMENTS, PROBLEMS, AND APPROACHES
An initial assessment of the various functional requirements for operation
of Bird Mark 7 IPPB units at the manufacturing and at the user level was con-
ducted. This assessment aided initial identification of potential problem areas
and also provided a preliminary definition of constraints under which design
and material modifications could be made.
1. Hospital Visits
Inhalation therapy departments at several Los Angeles University-affiliated
hospitals were visited to discuss and observe the hospitals' operating and hand-
ling of IPPB ventilators and thus obtain information on the operational conditions
to be met. The sterilization techniques currently in use were discussed in detail
in order to permit assessment of the impact of heat sterilization on hospital
operations. It does not appear that implementation of dry-heat sterilization will
create major problems except, in some instances, where there may be a short-
age of suitable dry-heat-sterilization equipment. This is a situation that can be
easily and cheaply rectified. The operational advantages of dry-heat sterilization,
compared to currently employed chemical-decontamination and gas-sterilization
methods, are many. Heat sterilization will permit a reduction in the man-hours
necessary to sterilize the units. In addition, as compared to gas sterilization,
it will reduce equipment "downtime", since no time will be needed for toxic gas
to leach out of the equipment. Various operating modes were identified, the
particular mode used to be dependent upon the type of accessory equipment used.
Hospital personnel emphasized the need for operational flexibility and ease of
adjustment of the units. The requirement to sterilize both ambient incoming air
and pressurized gas had been identified in Phase 0 of the program but was re-
emphasized during hospital visits.
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2. Manufacturer Visits
The Bird Corporation in Palm Springs was visited to discuss design
rationale of the equipment and its component parts. These discussions were
essential to the development of an understanding of the functional requirements
and economics of manufacturing, i. e., the factors which led the manufacturer
to his selection of materials as well as the configuration and fabrication of the
equipment for the Mark 7 design. Although material and fabrication costs were
not a prime criteria for the prototype heat-sterilizable units, it was essential
that, for the program to be of practical value, the ultimate manufacturing costs
of a redesigned unit be considered. The functional requirements of the major
elements of the assembly and the experience of the manufacturer in design evolu-
tion were discussed in detail. These discussions continued throughout the program
in order to make maximum use of the manufacturer's experience and expertise.
3. Data Review
Available information from prior JPL equipment-sterilization programs
was reviewed as an initial step in identification of potential problem areas, ap-
proaches, and fabrication materials which might be applicable to a modified de-
sign. A file of sterilization reports and of related materials technical data, app-
licable to dry-heat sterilization, was established for use throughout the program.
B. PRELIMINARY STERILIZATION COMPATIBILITY ASSESSMENT
Drawings and materials lists received from the manufacturer were reviewed
simultaneously with disassembly and examination of units. A principal product
of this assessment was identification of materials in the design which, based on
previous experience, were not expected to be suitable for heat sterilization.
The materials and assemblies in the unit were categorized as (1) problems,
(2) possible problems,' (3) probably acceptable, and (4) unknown. One or more
candidate replacement materials was identified for each material and/or part
which was expected to require replacement or modification.
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The physical, chemical, mechanical, and thermal properties of the existing
and proposed candidate materials were evaluated to determine their sterilization
compatibility. The prime consideration during this initial assessment was the
determination of thermal stability of these fabrication materials. The factors
that affect thermal stability are
1) Tensile stress (Fig. 6).
2) Tensile yield (Fig. 7).
3) Flexural modulus (Fig. 8).
4) Heat aging effects (Fig. 9).
5) Comparative creep behavior (Fig. 10).
6) Comparative heat deflection temperatures (Fig. 11).
In order to determine the suitability of a material for thermal applications,
it must first be determined whether the material will retain its initial properties
during continuous or long-term intermittent exposure to temperatures equal to,
or exceeding, those required. In addition, the thermal coefficient of linear
expansion and thermal conductivity must be analyzed to calculate the thermal
stresses which may develop. These stresses, which are usually incurred as a
result of differential thermal expansion, may, and usually do, occur under
transient conditions, where interacting parts are changing at different rates.
Another equally important consideration was the strength of the materials at
process temperatures. The possibility of oxidation, chemical reaction, and
vapor release had to be considered in light of possible toxicity problems and
interference with equipment function. Frequently, the above problem areas can
be readily and economically identified and verified by simple tests. Such tests
have advantages in addition to economy; one of the advantages is that the inadequacy
of materials can be demonstrated in a way that no amount of properties data can
approach, and unanticipated problems can be readily identified. An iterative
series of analyses, tests, and materials replacement or substitution was
utilized in achieving the ultimate sterilizable design in this program.
C. PRELIMINARY VERIFICATION TESTS
One of the Bird Mark 7 ventilators of the then-current design was evaluated
in two preliminary thermal tests. These tests were intended tb verify the identified
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materials problems, examine some of the potential problem areas, and to
identify unexpected problems. The first test consisted of 8 hours at 125'C with
the unit completely disassembled to evaluate the materials independent of inter-
action. The second test was for 24 hours at 1250 C with the unit completely
assembled. This second test resulted in additional thermal stability informa-
tion and preliminary interaction data.
As was expected, a number of parts sustained damage:
1) The polyvinyl chloride (PVC) breathing circuit hose softened during
the initial test and was torn by its own weight at attachment points
during the second (Fig. 12).
2) The acrylonitrile-butadiene-styrene (ABS) air mix control knob was
distorted and had to be removed prior to the second test.
3) Minor dimensional changes occurred in the polypropylene, polycar-
bonate, and nylon parts as a result of the first test.
4) The exhalation valve tee (polypropylene) was distorted along the
injection mold seam; thermal expansion differences caused an inter-
ference fit, preventing separation.
5) The end compartments (polycarbonate) showed extensive crazing,
cracking and dimensional distortion as a result of the second test
(Fig. 13).
6) Other polypropylene and nylon parts were distorted in varying
degrees.
7) The end compartment "0" rings changed dimension.
In addition to the above, the following conditions were observed as a
result of the tests:
1) The PVC tubing interconnecting control parts showed substantial
discoloration.
2) The pressure gauge needle indicated a permanent offset from the
zero point during each test.
3) The mask and test lung exhibited catastrophic failure with the mat-
erials softening beyond use. This result was completely unexpected
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since they were shown as neoprene rubber in the materials list.
They were obviously a combination of alternative materials. Replace-
ment with heat-sterilizable materials was considered feasible;
therefore, the materials which had caused the unexpected failure
were not investigated further.
The "case history" of the pressure gauge in the unit is significant to the
problem of heat sterilization of complex equipment. The gauge is a purchased
item and thus was listed on the parts/materials list without any details as to
design or materials of construction. It was identified as an unknown and thus
a potential problem area. The decision was made to evaluate it by testing
rather than by obtaining detailed data from the manufacturer and analyzing
the design.
During the initial tests it was observed that the zero-offset in the pressure
gauge was small and decreased with each cycle. Examination of the internal
construction of the gauge indicated the effect to be a minor relief of fabrication
stresses and not significant to the function of the gauge. This indication was
verified by subsequent extensive thermal cycle testing. The gauge then became
an item in the unit which would require a thermal-anneal cycle and reset of the
zero point and was no longer considered a potential problem area. Late in the
program, when units were being prepared for hospital field testing, assemblies
received from Bird included gauges which were nominally the same but which
failed during sterilization cycles. Disassembly of the gauge revealed that the
brass backing plate holding the gauge mechanism had been replaced with some
unidentified polymeric material. For most applications thid change would
not affect the function of the gauge, but for heat-sterilizable equipment the
gauge was no longer suitable. For equipment which is subject to heat-sterili-
zation temperatures, it is necessary to verify the suitability of the materials
and design and to assure that no changes are made which are critical to
sterilization compatibility.
D. MATERIALS REPLACEMENT
Following the initial tests, candidate replacement materials were selecte'd
for those which had failed or indicated probable long-term problems. The
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selection was based not only on fabrication processes which were applicable to
large-scale production but also on the functional requirements previously dis-
cussed with the hospitals and the manufacturer, as well as the inherent thermal
stability of the candidate materials. The unsatisfactory materials and their
candidate replacements are shown in Table 6.
Table 6. Presently used materials and replacement candidates*
Present Material Replacement Material
Polyvinyl chloride (PVC) Silastic rubber
Polypropylene (tenite or noryl) Polysulfone, Tefzel, Tenite-6PRO
Polycarbonate Polysulfone
Acrylonitrile-butadiene- styrene (ABS) Metal
Nylon (Zytel) Polysulfone
Acetal (Delrin) Polysulfone
*See Appendix B for identification of materials manufacturers.
Manufacturer's facilities in Palm Springs and Berkeley were visited to
discuss the replacement materials and fabrication problems that might be
associated with the use of these materials. The corporation agreed to provide
the suggested heat-sterilizable replacement parts as rapidly as possible. Owing
to the nature and cost of die installation in their injection-molding equipment,
considerable time elapsed before all replacement parts could be obtained. In
addition to parts fabricated from JPL-recommended materials, parts made of
other heat-sterilizable materials were also supplied for our evaluation.
In some cases mold-shrinkage differences between the original materials
and the replacement polysulfone resulted in dimensional mismatch of parts.
Design changes (see Section V) made it possible to compensate for these
differences in final dimensions without the requirement (and cost) for new or
modified molding dies.
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E. STERILIZATION SIMULATION TESTS
An existing Bird Mark 7 ventilator was retrofitted with all of the available
sterilizable replacement parts and a series of thermal cycles was initiated
duplicating the anticipated sterilization time and temperature parameters. The
experimental conditions consisted of 24 hour periods at 125OC, after which the
unit was physically examined and functionally tested at frequent intervals through-
out the investigation.
The test configuration included molded polysulfone replacement parts for
the polycarbonate ambient and pressure compartment covers, as well as poly-
propylene exhalation valve and tubing ties. Some of polypropylene micronebulizer
parts were replaced with polysulfone parts and others with Valox. All tubing
was changed to silicone rubber.
After the third cycle - i.e., 72 hours at 125 0 C - the unit was functionally
tested for 12 hours using a nitrogen gas source. No malfunctions were noted.
At the same time, a smoke test was performed to examine the possibility of
backflow of air through the head assembly and to study the flow of incoming ambient
air. The test indicated that there was no apparent backflow through the breathing
circuit. The smoke test also indicated that ambient air entered the ambient
compartment approximately equally through the existing micromesh filter and
through other openings in the compartment. The micromesh filter, recognized
to be ineffective in filtering out bacteria, was furthermore filtering only approxi-
mately half of the incoming air. JPL modifications eliminated this filter (and
the need for sealing the existing ambient compartment leaks - see Section VI).
F. INITIAL THERMAL EFFECTS
Inspection and test after the 10th cycle (240 hours at 125'C) indicated
operational malfunction. The unit was completely disassembled and examined
in detail for material degradation and dimensional changes. The following
conditions were observed during this test series:
1) Surface crazing was observed at the tapered fitting joint between
the micronebulizer and the exhalation valve' after 5 cycles
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(120 hours at 125°C). Cracking was noted after 168 hours at temper-
ature; this degradation was the result of excessive stress during the
thermal cycle. Subsequently, parts were satisfactorily sterilized
with this joint separated. The joint was reconnected after sterilization,
while still bagged.
2) Pink discoloration of the silicone tubing was noted after 216 hours
at temperature (9 cycles); this was considered to be caused by
deposition of outgassing products from the lubricant and/or neoprene
parts. Both were subsequently changed.
3) After the 10th cycle the air mix control rod ceased to function
properly, and the ceramic valve was constrained in the inspiratory
position by the diaphragm assembly. The neoprene 0-rings on the
control rod had hardened and deformed and the lubricant had evap-
orated. The neoprene diaphragm had distorted and hardened, con-
straining the ceramic valve. To correct the problems, the control
rod 0-rings and diaphragm were replaced with silicone rubber and
silicone oil was substituted for the original lubricant.
4) Neoprene centerbody 0-rings degraded, hardened, changed dimensions
and shape, and took a permanent set. Samples were tested and it was
found that, after the 10th cycle, tensile strength had decreased 10%;
elongation decreased by 50%; and hardness had increased by 10%.
All neoprene 0-rings were replaced with silicone rubber.
5) The polysulfone pressure compartment cover evidenced some distor-
tion, crazing, and cracking as a result of excessive thermal stresses
during the tests. Modification of the compartment attachment and
seal designs was required.
G. ADDITIONAL CHANGES AND REPLACEMENTS
Following the test series described above, thermal cycling was suspended
to permit incorporation of the necessary design changes and fabrication of
additional sterilizable parts. Three units were retrofitted with replacement parts
for continuation of thermal testing. In these units all 0-rings and the diaphragm
were replaced with silicone rubber and all lubrication was done with silicone
oil. Most of the molded parts were replaced with polysulfone. A few of the parts
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in the exhalation valve and micronebulizer were available only in Tefzel and
Valox because of molding problems associated with polysulfone; the small size
and shape of these parts; and the use of original dies which could not compensate
for the difference in thermal expansion of the polysulfone material.
The three units also differed in the configuration of the 0-ring seal for the
end compartments; two had new 0-ring designs and the third used essentially the
existing design.
The first two cycles on these three units were run at 125 0 C for 24 hours
to evaluate the effects of possible temperature override in the oven during
sterilization. After these two cycles, the units with the new 0-ring configuration
(see Section V, Design Modification) developed stress cracks and crazing in the
areas where the "0" exerted excessive pressure. The original 0-ring groove
configuration did not show the same effect in this test. The configuration of the
0-ring groove in the compartment and the 0-ring were modified to reduce the
thermal stresses in these areas for the new design.
Subsequent to this change, the three units were subjected to 20 cycles of
24 hours at 125°C (a total of 528 hours at temperature) without additional
failures except for some minor crazing of the polysulfone parts. This crazing
only occurred in the threaded areas where the magnetic controllers are attached
to the compartment and in the threaded area of the exhalation valve. Correction
of this problem was achieved by relieving the threaded areas (increased
tolerances).
H. BAGGING MATERIALS
To assure unit sterility for patient use, a reliable system was needed that
would preclude exposure of the assembly to microbial contamination during
handling and storage between sterilization and patient use. It was decided that
the required protection could be achieved by sealing the entire assembly in a
disposable bag after cleaning and prior to heat sterilization and by maintaining
the seal throught sterilization and storage. It was recognized that, in routine
hospital use, some sort of a reusable "zip lock" bag might be advisable rather
44 JPL Technical Memorandum 33-670
than the heat-sealed bags used in this study. However, development and evalua-
tion of such an approach was not deemed essential to achievement of demonstra-
ted heat sterilizability and was accordingly considered beyond the scope of this
investigation.
With incorporation of proposed design changes, particularly in the area
of filtration of both pressurized gases and ambient air, it is only necessary to
preserve sterility of those parts and surfaces which are not protected by the
filtration system, such as the external portions of the breathing head, by clo-
sures over the ports where bacterial entry might possibly occur.
Materials for bagging were evaluated on the basis of a requirement for
heat-sealable, single-use bags which would not produce toxic byproducts, would
withstand the sterilization cycle, and would assure maintenance of sterility. No
attemptwas made to optimize selection with respect to cost, ease of fabrication,
and possible reuse. Capran, a nylon film available in adequate size in roll form,
and heat sealable with available heat sealing equipment, was found to meet the
requirements of this program and was used for bagging of all test units prior to
sterilization.
I. BACTERIA-RETENTIVE FILTERS
Commercially available filters were reviewed for air flow resistance,
particle migration, outgassing, thermal stability, size, cost, ventilator com-
patibility, and suitability for absolute filtration of incoming ambient air and pres-
surized gases. No commercial filters could be found which would meet all of
these requirements; therefore, it was decided to design and fabricate a filter
system which would be compatible with the modified unit (see Section VI).
J. FIELD TESTS OF PROTOTYPE UNITS
Sterilizable ventilators, fabricated with replacement materials and incor-
porating design changes developed during previous phases of the program, were
prepared for hospital field test. The equipment consisted of six control units
fabricated to the new design by Bird Corporation and equipped with air and pres-
sure gas filters fabricated by JPL. In addition, 36 sterilizable head assemblies
were assembled by Bird Corporation. The large number of head assemblies
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permitted more effective utilization of the field units in obtaining statistical
data on the efficacy of the various sterilization cycles. The extra head assem-
blies permitted exposure to patient contamination after sterilization, without
the undue delay that would result from the turnaround time of the control assem-
blies.
The primary objective of the field test was to develop data on the sterili-
zation reliability of various cycles. These results are discussed in Section III
of this report. In addition, the field test sterilization cycles provided an oppor-
tunity for verification of the materials and design of the heat-sterilizable assem-
bly. Some minor problems were encountered as a result of this test. The fail-
ure of the pressure gauge has been described earlier. Two units were described
by inhalation therapy personnel as exhibiting "erratic performance" during
operation. Subsequent disassembly failed to reveal any mechanical malfunction,
except an offset in the pressure gauge. It was shown that the erratic behavior
was the result of improperly indicated pressure which led to improper adjust-
ment of the units. Correction of the gauge deficiency is accomplished by use
of an interior metal "backing plate, " as described above (Section IV-C).
K. THERMAL ANALYSIS AND TEST
As discussed in Section III, the probability of achieving sterility by the use
of a given heat-sterilization process is dependent on temperature and time. For
a device such as the IPPB ventilator, the thermal cycle must be defined to assure
that the element of the assembly with the slowest thermal response is held at the
required temperature for the length of time necessary to attain sterility. Pre-
liminary assessment indicated that, although the thermal lag could be analyzed,
an experimental approach would not only be more practical but more reliable.
The assembly was therefore examined in view of identifying the extremes of
thermal lag time and the appropriate location of thermocouples for subsequent
thermal testing.
One of the partially retrofitted IPPB units was instrumented with thermo-
couples in selected locations. Data were recorded on a multipoint recorder
and subsequently analyzed for maximum and minimum thermal lag time. As
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expected, the control assembly centerbody, with its large thermal capacity and
limited conduction path, showed the maximum thermal lag. Other instrumented
parts of the control assembly had thermal response times almost identical to
those of the centerbody. A comparison of the thermal test data with oven temper-
ature readings demonstrated that leaving the units in an oven for a specified
time at the temperature indicated by the oven thermometer does not give a true
indication of the "time at temperature" of the units. Thermocouples or some
other temperature-sensing device should be attached to the centerbody of the
most centrally located unit in the oven to determine when the units reach the
sterilizing temperature selected. If the load consists of plastic parts only, the
thermocouple should be attached to the part nearest the center of the load. If a
direct temperature indicating device is not available, the sterilization time must
be extended to increase the probability that the units were subjected to the re-
quired "time at temperature. " The time required to reach temperature is a
function of load, load distribution, oven characteristics, and restrictions to
effective heat transfer from the oven to the coldest unit and must be established
for the load and the oven.
During sterilization of the hospital field test units, one of the units was
instrumented to determine the thermal lag and thus establish the total time
during each cycle that the coldest parts of the units were at 125 C. An oven,
0. 68 cu m (24 cu ft), utilizing a blower to circulate heated air, was used in
these tests. Six control heads and 16 complete breathing circuits, including
all tubing and fittings, were bagged separately and sealed. A thermocouple
was attached to a bagged control centerbody which had been shown to have the
greatest thermal lag. This bagged unit was placed in the center of the oven
and surrounded by the remaining bagged units. Repeated tests indicated that
it required a maximum of 1 hour for the instrumented centerbody to reach 125 C .
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SECTION V
DESIGN MODIFICATIONS
To achieve a heat-sterilizable breathing apparatus, a number of design
revisions were found to be necessary. These alterations resulted from required
material changes and stresses encountered during thermal cycling of a com-
pletely assembled unit.
The major design revisions were made in the pressure compartment end
cover of the control unit. These changes, which involved new sealing and attach-
ment techniques, are described below.
A. SEALING TECHNIQUES
Functioning of the device requires that the pressure compartment maintain
a continuous seal under varying pressures during operation. Changes in the
seal between the aluminum centerbody and the end cover were required to pre-
vent undue stresses, with resultant material failure, during heat sterilization
and subsequent operation of the unit. The existing design for the pressure com-
partment cover is shown in Fig. 14. The revised design shown in Fig. 15 per-
mitted heat sterilization and also permitted direct replacement of the present
heat-sensitive plastic covers with polysulfone covers having the same configura-
tion, thus eliminating the expense and delay which would have been associated
with fabricating new dies. The design modifications involved changing the posi-
tion and shape of the O-ring groove and installing an O-ring with a smaller cross
section.
B. ATTACHMENT TECHNIQUES
In the original design, the molded pressure compartment cover was
counterbored to a thin (2.160 mm) section at the attachment points. Assembly
stress loads, as well as thermal stress loads, caused cover failure at this
point. In addition, installation of the mounting screw imposed excessive com-
pression loads on this thin section. The revised design is accomplished without
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-, - 3.81 MM
3.16 MM DIA. O-RING
CENTERBODY
, - 2.160 MM- PRESSURE
COMPARTMENT
0 Problems:
The compartment applied compression loads against the O-ring for sealing.
Crazing occurred at the corners of the compartment where the O-ring loading was
highest when the unit was heat cycled.
0
The recess for the mounting studs rendered the compartment too thin to hold the O-ring
in compression, thereby producing excessive stress around the mounting points.
Fig. 14. Existing centerbody and pressure compartment
O
STUD 0.76 MM MIN
---- O-RING GROOVE
FIG.
316
/
Resolution of the Problems:
The O-ring, groove size, and groove location were changed to permit the O-ring to
seal by pressing against the side walls of the compartment rather than the bottom edge.
A gap was maintained between the bottom edge of the compartment and the centerbody
to eliminate compression loads on the compartment.
The fastening technique was also revised as shown in the above figure.
Fig. 15. Centerbody and pressure compartment modification
new or modified tooling. Instead, it is achieved by changing fabrication from
a counterbore to a through bore, and adding a shoulder washer and O-ring to
eliminate high installation stress and thermal stress failures in the attachment
area. Compression loads are now eliminated by means of the shoulder washer,
and compartment sealing is accomplished by means of the O-ring which also
seals arnunrl the mounting screws.
It was also necessary to modify the stud length in order to accommodate
the new attachment mode and to guarantee clearance between the cover and
centerbody.
In the original design, the cover/centerbody seal is achieved by compart-
ment pressure on the centerbody O-ring, applied by tightening the mounting
screw. This scheme puts unacceptable loads on the cover in the area of the 0-
ring, and in the thin section of the cover in contact with the stud. These loads
were responsible for cracking observed in the first thermal cycling of the origi-
nal polycarbonate covers and for less dramatic cracking observed in the replace-
ment polysulfone covers when using the original configuration. The original
design produced excessive loads in these two areas, even without heat steriliza-
tion. Pressure compartment covers had a very high frequency of replacement
in the original design.
The final revised configuration, with the significant changes at the O-ring
seal and method of attachment, is shown in Fig. 15. Details of the attachment
point configuration can be seen in Fig. 16. Note that the cover is now free to
slide over the centerbody O-ring, and there is no possibility of load on the
compartment as a result of physical contact with the centerbody. The loads
exerted on the cover from the centerbody, transmitted through the O-ring, are
now controllable by the relative dimensions of the cover, the O-ring, and the
O-ring groove. The differential expansion between the polysulfone cover and
the aluminum centerbody now tend to relax, rather than increase the loads on
the cover and on the O-ring at elevated temperatures during sterilization. In-
correct dimensional relationship was responsible for cracking of the cover in
the first prototype revised configuration. In the final configuration the cracking
was completely eliminated by the reduction in O-ring diameter and correction
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oNN
O-RING
SHOULDER WASHER STUD
Resolution of the Problems:
The shoulder washers are designed to protect the cover from crushing loads caused
when torque is applied to the screw.
The O-ring is used to seal around the holes and to position the cover.
* ENGLISH MEASURE
Fig. 16. Compartment mounting detail
W-
of the O-ring groove dimension. The O-ring in the new configuration, resting
in a conventional O-ring groove, also facilitates assembly and disassembly.
The new seal configuration required no new or modified tooling for the
cover or centerbody to accommodate the improved design. Some additional
changes in the cover configuration would have been desirable, but were not essen-
tial to demonstrate a capability for reliable heat sterilization. Comparison of
the O-ring installation in the centerbody in Figs. 12 and 13 show the difference
in original and final configuration. The centerbody consists of a complex casting
and represents a major cost element of the total assembly. The new configura-
tion was designed to permit fabrication of the centerbody from existing tooling
with changes only in the final machining (to preclude the delay and cost associa-
ted with retooling). The units for hospital field tests were machined to this
configuration by the Bird Corporation from centerbody castings made with the
same tooling used for the existing design. Although it is not possible, without
some filling, to remachine centerbodies of existing units in the field to this con-
figuration, there are slightly modified designs which can be used for the O-ring
and groove which will permit retrofit of existing units.
The Bird Corporation manufactures a number of accessory items used in
various combinations with the basic Mark 7 ventilator. These accessories are
used in various configurations. The system configuration used for most of the
heat-cycle testing, and all of the hospital testing, is that identified by Bird as
the "Q Circle System. " Conceptual designs for reliable heat sterilization and
maintenance of sterility were developed for the "parallel inspiratory system"
and the "oxygen blender system. " There are configurational and hardware
availability problems associated with these latter two configurations, but they
have been shown to be at least conceptually feasible. Demonstration of these
other configurations was considered beyond the scope of the program and there-
fore they were not investigated.
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SECTION VI
FILTRATION OF AMBIENT AIR AND PRESSURIZED GASES
A. METHODS
The cover of the ambient-pressure side of the unit is not sealed in either
the original or new design, and an O-:ring is not used in either case. A change
similar to that used for the positive-pressure side would have been required to
maintain sterility of the machine and prevent contamination of the air stream
from the surrounding atmosphere, if it were not for a new filter attachment con-
figuration. In the new design, air from the ambient filter feeds directly into a
sealed venturi, as does the pressurized "drive" gas (Fig. 4). Thus, in the new
design the ambient compartment housing is essentially only a dust cover.
To attain the essential filtration efficiency as described in Section III and
to meet the gas flow requirements of the Mark 7 ventilator, it was necessary to
design and produce a new filter system.
The ambient air filters for hospital tests were fabricated by JPL, using a
polysulfone 500 cc nebulizer supplied by Bird Corporation as the filter material
container or housing. This particular .container was used for expediency, since
it was approximately the correct size, volume-wise, and the existing fittings
were adaptable to the unit (see Fig. 17).
The pressurized gas filters were fabricated using a housing machined by
Bird and based on a design and prototype originally built at JPL (Fig. 18).
The filters have the following characteristics:
1) They can withstand hundreds of hours of sterilization at 125 C.
2) They are capable of absolute microbial filtration.
3) They retain their high flow characteristics for long periods of time.
4) They do not produce toxic products during sterilization or use.
5) They are not subject to injury from normal handling or processing.
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FIBERGLASS FILTER MEDIUM
URETHANE FILTER MEDIUM
RING ASSEMBLY WIRE
MESH BONDED TO RING
DOWEL PIN SPACERS
URETHANE FILTER
MEDIUM
Fig. 17. Ambient filter
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URETHANE FILTER MEDIUM
FIBERGLASS FILTER MEDIUM
Fig. 18. Pressure (gas) filter
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6) They are protected from "packing" by built-in spacers.
7) The pre- and post-filters of urethane foam prevent premature plug-
ging from dust particles and migration of the bacteria-retentive
filter medium.
B. MATERIALS
The compound filter materials used in both configurations were as follows:
1) Bacteria-retentive filter medium: FM-004 Pyrex fiberglas wool
filter material.
2) Dust and Media Migration Filter: Scott Filter Foam.
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APPENDIX A
LETTER FROM BIRD CORPORATION
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bird MARK 7 palm springs california 922s2
telegraph cable address markfour palm springs
telephone 4I aa=7 si
27 December 1972
Mr. Alex S. Irons
Jet Propulsion Laboratories
California Institute of Tech.
4800 Oakgrove Drive
Bldg. 233, Room 206
Pasadena, Calif. 91103
Dear Mr. Irons:
We at bird Corporation are very gratified at the progress
being made by your group in suggesting materials, designs
and procedures which will permit us to convert one or more
of our respirator designs to materials and construction
able to withstand repeated dry heat sterilization. We are
thoroughly convinced that the dry heat method of steriliza-
tion is far superior to other methods of sterilization cur-
rently available and in use for this type of equipment.
Consequently, we intend to incorporate dry heat steriliza-
tion capability as a major design criterion in all bird
products wherever it is technologically and economically
feasible. Because of the enthusiasm generated for the
hea.t sterilization concept through our work with your group
on the MARK 7@ design we have also undertaken a parallel
project, that of converting the MARK 1® design to heat
sterilizable materials. This is a simpler task than the
MARK 7@ conversion since it is a much smaller and simpler
device and, as you know, we are just about ready to pro-
duce several hundred of these units and introduce them to
the field on a fairly large scale for evaluation.
We are confident the results will confirm our confidence in
dry heat sterilization as the most efficient and effective
method for inhalation therapy and most other hospital equip-
ment.
Sincerely,
bird Corporation Precedig page blank
W. C. Bentinck
iml
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APPENDIX B
MATERIALS MANUFACTURERS
1. Polysuffone
Union Carbide Corporation
Plastics Division
270 Park Avenue
New York, New York 10017
2. Silicone Silastic Rubber - Dow-Corning
The Fluorocarbon Co., Cole Rubber and Plastics
1032 Morse Avenue
Sunnyvale, California 94088
3. Tefzel
DuPont Corporation
Wilmington, Delaware
4. Tenite - 6PRO (Polyterephthalate)
Eastman Chemical Products, Inc.
Subsidiary of Eastman Kodak
Kingsport, Tennessee
5. Polypropylene
Amoco Chemicals Corp.
Chicago, Illinois
6. Capran - Nylon - 6 Film
Allied Chemical Co.
Plastics Division
Morristown, New Jersey
7. FM-004 Pyrex fiberglas wool filter material
Owens-Corning Fiberglas Corporation
Toledo, Ohio
8. Scott filter foam
Industrial Sales Department
Foam Division
Scott Co.
1500 East Second Street
Chester, Pa. 19013
Preceding page blank
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